National

Estimated cost of fire damage in S. California to exceed 250 bln USD

Jan 25, 2025

Albany [New York], January 25: As raging wildfires continue to torment Southern California, estimates of the total economic loss have ballooned to more than 250 billion U.S. dollars, making it one of the most costly natural disasters in U.S. history.
"Early estimates by AccuWeather and JP Morgan put the damage in the 50 billion dollars range, but the expected toll quickly rose to more than triple that amount as fires spread through neighborhoods in Altadena, Pacific Palisades and Malibu," reported the Los Angeles Times on Friday.
In the last two days, hundreds of weary firefighters have battled multiple fires in the hills around Los Angeles and Ventura counties, including a massive blaze near Castaic, an early morning fire in the Sepulveda Pass that threatened the tony communities of Brentwood and Bel-Air, and another that pushed into Ventura County farmland Thursday morning.
The latest estimate from weather forecasting service AccuWeather puts the total expected damage and economic loss to between 250 billion dollars and 275 billion dollars. That includes the costs of damage, loss of life, healthcare, business disruptions and other economic impacts.
Source: Xinhua News Agency

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026